Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study74

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study30

Views

Views
May 20250
June 20252
July 202518
August 20250
September 20256
October 20250
November 20254
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Brazil7
United Kingdom5
Argentina1
Canada1
Chile1
Ethiopia1
Kenya1
Mexico1
Paraguay1
 

Top cities views

Views
Awasa1
Camaquã1
Canoas1
Careaçu1
Ciudad del Este1
Concepción1
Contagem1
Dallas1
Edinburgh1
Fairburn1